DOSIO, Franco
DOSIO, Franco
SCIENZA E TECNOLOGIA DEL FARMACO
2,3,4,5-tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling.
1994-01-01 Grosa G.; Ceruti M.; Dosio F.; Brusa P.; Cattel L.
2,3,4,5-Tetrahydroxy-5-(4-hydroxyphenyl)valeric acid: a new cleavable monofunctional reagent for monoclonal antibody labeling.
1994-01-01 Grosa G.; Dosio F.; Brusa P.; Ceruti M.; Delprino L.; Cattel L.
2-Aza-2,3-dihydrosqualene: biodistribution and pharmacokinetic properties in mice.
1993-01-01 Brusa P.; Dosio F.; Ceruti M.; Grosa G.; Cattel L.
A convenient synthesis of [3-3H]squalene and [3-3H]-2,3-oxidosqualene.
1994-01-01 Ceruti M.; Grosa G.; Rocco F.; Dosio F.; Cattel L.
A new "solid phase" procedure to synthesize immunotoxins (antibody-ribosome inactivating protein conjugates).
1993-01-01 Dosio F.; Brusa P.; Delprino L.; Ceruti M.; Grosa G.; Cattel L.
A new 'blocked' immunotoxin
1987-01-01 L. Cattel; P.M. Comoglio; L. Delprino; P. Brusa; F. Dosio; M. Prat
A new approach in the synthesis of immunotoxins: ribosome inactivating protein non-covalently bound to monoclonal antibody
1993-01-01 F. Dosio; P. Brusa; L. Cattel
A new approach in the synthesis of immunotoxins: ribosome inactivating protein noncovalently bound to monoclonal antibody.
1994-01-01 Dosio F.; Brusa P.; Delprino L.; Grosa G.; Ceruti M.; Cattel L.
A new class of linkers: open chain thioimidate derivatives
1991-01-01 L. Cattel; M. Giacomotti; F. Dosio; P. Brusa; L. Delprino
A new generation of immunotoxins: cytotoxins non-covalently bound to monoclonal antibodies
1992-01-01 F. Dosio; P. Brusa; L. Cattel
A new method to synthesize immunotoxins using non-covalent interactions
1992-01-01 F. Dosio; P. Brusa; L. Cattel
A unique squalenoylated and non pegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity
2014-01-01 A. Maksimenko; F. Dosio; J. Mougin; A. Ferrero; S. Wack; L.H. Reddy; A. Weyn; E. Lepeltier; C. Bourgaux; B. Stella; L. Cattel; P. Couvreur
A unique squalenoylated and nonpegylated doxorubicin nanomedicine with systemic long-circulating properties and anticancer activity.
2014-01-01 S. Mura; A. Maksimenko; F. Dosio; J. Mougin; A. Ferrero; S. Wack; L.H. Reddy; A.A. Weyn; E. Lepeltier; C. Bourgaux; B. Stella; L. Cattel; P. Couvreur
Active targeting of squalenic nanoparticles
2009-01-01 S. Bolognesi; B. Stella; F. Dosio; A. Ferrero; L. Cattel
Advances in anticancer antibody-drug conjugates and immunotoxins.
2014-01-01 F. Dosio; B. Stella; S. Cerioni; D. Gastaldi; S. Arpicco
An original approach in the synthesis of immunotoxins: conjugation in heterogeneous phase
1992-01-01 F. Dosio; P. Brusa; L. Cattel
An original approach to conjugate monoclonal antibody and cytotoxic proteins in heterogeneous phase
1992-01-01 F. Dosio; P. Brusa; L. Delprino; L. Cattel
Antibody-targeted leucinostatin A
1994-01-01 F. Dosio; M. Ricci; P. Brusa; C. Rossi; L. Cattel
Antibody-toxin conjugate preparation: effects of the linker on activity and stability
1989-01-01 F. Dosio; T. Cogliati; S. Canevari; D. Mezzanzanica; P. Brusa; L. Delprino; M.I. Colnaghi; L. Cattel
Antibody-toxin conjugates: chemistry of coupling and purification
2002-01-01 CANEVARI S.; COLNAGHI M.I.; CATTEL L.; F. DOSIO